Market Tracker

05/22 5:16pm ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

2.65
Delayed Data
As of 3:59pm ET
 -0.2428 / -8.39%
Today’s Change
2.12
Today|||52-Week Range
5.29
-19.70%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close2.89
Today’s open2.80
Day’s range2.50 - 2.80
Volume67,991
Average volume (3 months)16,853
Market cap$44.3M
Dividend yield--
Data as of 3:59pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)+79.47%
Earnings growth (this year)+64.11%
Earnings growth (next 5 years)--
Revenue growth (last year)+171.56%
P/E ratioNM
Price/Sales2.61
Price/Book6.22

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...-0.18-3.92%
ITEKInotek Pharmaceutica...+0.05+2.86%
OREXOrexigen Therapeutic...-0.12-3.81%
AMPEAmpio Pharmaceutical...+0.02+2.05%
Data as of 4:01pm ET, 05/22/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$11.9M
Annual profit (last year)-$13.2M
Net profit margin-110.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts